NPPB and pulmonary arterial hypertension: to HENRY with BNP and NT-proBNP, the most important biomarkers for heart failure, and vascular endothelial growth factor D (VEGFD), a novel biomarker for left pulmonary hypertension subsequent to left heart disease [15], can be regarded as general proof of the principles of the present analyses.